Evidence map›Paper›PMID 27453577›Full record

ArticleAmerican journal of human genetics2016

Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy.

Michael S Hildebrand, Nicole G Griffin, John A Damiano, Elisa J Cops, Rosemary Burgess, Ezgi Ozturk, Nigel C Jones, Richard J Leventer, Jeremy L Freeman, A Simon Harvey and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Protein Kinase A in neurological disorders.Journal of neurodevelopmental disorders · 2024
    Review
  7. Advances in epileptic network findings of hypothalamic hamartomas.Journal of central nervous system disease · 2024
    Review
  8. Cytogenomic epileptology.Molecular cytogenetics · 2023
    Review
  9. Article
  10. Review
  11. Somatic mosaicism in the diseased brain.Molecular cytogenetics · 2022
    Review
  12. Article
  13. The changing landscape in epilepsy imaging: Unmasking subtle and unique entities.Diagnostic and interventional radiology (Ankara, Turkey) · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Sonic Hedgehog Signaling in Cerebellar Development and Cancer.Frontiers in cell and developmental biology · 2022
    Review
  18. Review
  19. Description of a giant hypothalamic hamartoma associated with an immature ruptured giant sacrococcygeal teratoma: a case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Michael S HildebrandEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia.
Nicole G GriffinInstitute for Genomic Medicine, Columbia University, New York, NY 10032, USA.
John A DamianoEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia.
Elisa J CopsEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia.
Rosemary BurgessEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia.
Ezgi OzturkDepartment of Medicine, The University of Melbourne and The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
Nigel C JonesDepartment of Medicine, The University of Melbourne and The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
Richard J LeventerDepartment of Neurology, The Royal Children's Hospital, Parkville, VIC 3052, Australia; Department of Paediatrics, University of Melbourne and The Royal Children's Hospital, Parkville, VIC 3052, Australia; Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Jeremy L FreemanDepartment of Neurology, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
A Simon HarveyDepartment of Neurology, The Royal Children's Hospital, Parkville, VIC 3052, Australia; Department of Paediatrics, University of Melbourne and The Royal Children's Hospital, Parkville, VIC 3052, Australia; Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Lynette G SadleirDepartment of Paediatrics and Child Health, University of Otago, Wellington 9016, New Zealand.
Ingrid E SchefferEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia; Department of Paediatrics, University of Melbourne and The Royal Children's Hospital, Parkville, VIC 3052, Australia; The Florey Institute of Neuroscience and Mental Health, Parkville, VIC 3052, Australia.
Heather MajorDepartment of Pediatrics, The University of Iowa, Iowa City, IA 52246, USA.
Benjamin W DarbroDepartment of Pediatrics, The University of Iowa, Iowa City, IA 52246, USA.
Andrew S AllenDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, USA.
David B GoldsteinInstitute for Genomic Medicine, Columbia University, New York, NY 10032, USA.
John F KerriganDivision of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85013, USA.
Samuel F BerkovicEpilepsy Research Center, Department of Medicine, The University of Melbourne and Austin Health, Heidelberg, VIC 3084, Australia. Electronic address: s.berkovic@unimelb.edu.au.
Erin L HeinzenInstitute for Genomic Medicine, Columbia University, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA. Electronic address: eh2682@cumc.columbia.edu.
University of Melbourne · AUColumbia University · USAustin Health · AURoyal Children's Hospital · AUUniversity of Iowa · USBarrow Neurological Institute · USDuke University · USMurdoch Children's Research Institute · AUThe Royal Melbourne Hospital · AUUniversity of Otago · NZ

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Exploratory genomic investigations of mesial temporal lobe epilepsyR21NS078657 · NINDS · DUKE UNIVERSITY · PI HEINZEN, ERIN L · 2012 to 2013
$425k
NINDS NIH HHS R21 NS078657
6 · The paper itself

Abstract

Hypothalamic hamartoma (HH) with gelastic epilepsy is a well-recognized drug-resistant epilepsy syndrome of early life.(1) Surgical resection allows limited access to the small deep-seated lesions that cause the disease. Here, we report the results of a search for somatic mutations in paired hamartoma- and leukocyte-derived DNA samples from 38 individuals which we conducted by using whole-exome sequencing (WES), chromosomal microarray (CMA), and targeted resequencing (TRS) of candidate genes. Somatic mutations were identified in genes involving regulation of the sonic hedgehog (Shh) pathway in 14/38 individuals (37%). Three individuals had somatic mutations in PRKACA, which encodes a cAMP-dependent protein kinase that acts as a repressor protein in the Shh pathway, and four subjects had somatic mutations in GLI3, an Shh pathway gene associated with HH. In seven other individuals, we identified two recurrent and three single brain-tissue-specific, large copy-number or loss-of-heterozygosity (LOH) variants involving multiple Shh genes, as well as other genes without an obvious biological link to the Shh pathway. The Shh pathway genes in these large somatic lesions include the ligand itself (SHH and IHH), the receptor SMO, and several other Shh downstream pathway members, including CREBBP and GLI2. Taken together, our data implicate perturbation of the Shh pathway in at least 37% of individuals with the HH epilepsy syndrome, consistent with the concept of a developmental pathway brain disease.

Indexed as

CREB-Binding ProteinCyclic AMP-Dependent Protein Kinase Catalytic SubunitsEpilepsies, PartialExomeFemaleHamartomaHedgehog ProteinsHumansHypothalamic DiseasesKruppel-Like Transcription FactorsLoss of HeterozygosityMaleMutationNerve Tissue ProteinsNuclear ProteinsSignal TransductionCREB-Binding ProteinCREBBP protein, humanCyclic AMP-Dependent Protein Kinase Catalytic SubunitsGLI2 protein, humanGLI3 protein, humanHedgehog ProteinsKruppel-Like Transcription FactorsNerve Tissue ProteinsNuclear ProteinsPRKACA protein, humanSHH protein, humanZinc Finger Protein Gli2Zinc Finger Protein Gli3

Identifiers

PMID27453577
PMCPMC4974069
OpenAlexW2489722909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.